European Archives - Page 187 of 1000 - European Medical Journal

Digital Interventions for Psoriatic Arthritis Screening in Primary Care

Psoriasis (PsO) is a chronic inflammatory skin condition that affects around 2% of the population in Europe…

Artificial Intelligence in Robotic Urologic Surgery

This infographic explores the emerging role of artificial intelligence in robotic urologic surgery, with a spotlight on the current…

Spotlight: April 2024

Catch up on the top stories to come from the pharma industry over April, including new collaborations set to improve treatments for patients, the latest approvals and more.

Muscle Matters: Protein Requirements for Muscle Preservation During Ageing

This infographic aims to raise awareness among healthcare providers about the importance of protein intake for muscle preservation in…

New Artificial Intelligence Improves Paediatric Scoliosis Monitoring

AI predicts paediatric bone growth more accurately than standard methods, revolutionizing scoliosis monitoring and improving patient care with easily scalable technology.

Tongue Hyperpigmentation With Peginterferon α-2b Therapy in Hepatitis B

Peginterferon α-2b (Peg IFNα-2b), which inhibits viral replication in infected cells, suppresses cell proliferation, induces apoptosis, and…

Dialysis Breakthrough: Medical Catheter Insertion Matches Surgical Standard

A ground breaking study comparing non-surgical (medical) insertion of abdominal catheters for peritoneal dialysis to traditional surgical methods has unveiled promising results.

Lupus Linked to Cognitive Dysfunction

Research shows systemic lupus erythematosus patients have lower fluid cognition levels, especially in attention and inhibitory control. Addressing cognitive impairment is crucial for improving patient outcomes.

Rheumatic Diseases and Reproductive Health: Effects on Pregnancy

Study finds immune-mediated diseases increase risks in pregnancy, impacting reproductive success. Early planning and awareness are essential for better management.

Poor return on investment rates on the rise

The pharma industry’s ability to recoup costs on their drug development pipeline was in trouble, been is the downward spiral coming to an end? Read more.